| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/07/2004 | CN1465592A Human Interleukin-17 receptor sample protein, and coding gene and use thereof |
| 01/07/2004 | CN1465591A Affinity functional zone cell anchoring factor for amino acid sequence arginine-glycine-aminosuccinic acid/cellulose and preparation method thereof |
| 01/07/2004 | CN1465590A Recombination main outer membrane protein of parrot fever chlaydozoan, and preparation process and use thereof |
| 01/07/2004 | CN1465589A Gene recombination SARS virus coat protein S and preparation process thereof |
| 01/07/2004 | CN1465587A Polypeptide-chondriosome carrier 18 and polynucleotide for colding said polypeptide |
| 01/07/2004 | CN1465584A SiRNA target sequence bank of SARS virus and use thereof |
| 01/07/2004 | CN1465402A Recombination protein vaccine for preventing animal aphtha virus infection |
| 01/07/2004 | CN1465400A Preparation and application for human carcino-embryonic antigen and cell differentiation antigen 40 ligand fused tumor vaccine |
| 01/07/2004 | CN1133745C Method for immortalizing cells and immortalized cell |
| 01/07/2004 | CN1133744C New high capacity binary shuttle vector |
| 01/07/2004 | CN1133743C Modified clotting Factor VII |
| 01/07/2004 | CN1133650C A method of identifying CFTP-binding compounds useful for activating chloride conductance in animal cells |
| 01/06/2004 | US6675105 Structure-based identification of candidate compounds using three dimensional structures and models of Fc receptors |
| 01/06/2004 | US6675104 Method for analyzing mass spectra |
| 01/06/2004 | US6673990 Biopesticides |
| 01/06/2004 | US6673988 Plant lipases |
| 01/06/2004 | US6673986 Transgenic mouse; deactivated endogenous immunoglobulin heavy chain loci; gene expression |
| 01/06/2004 | US6673918 One pot deprotection of preferential nucleotide sequences; obtain nucleotide sequences, incubate with triethylamine at room temperature, incubate with anhydrous triethylamine hydrogen fluoride, heat, recover nucletide sequences |
| 01/06/2004 | US6673917 Antiapoptotic agents for use as viricides and anticarcinogenic agents; autoimmune disorders, and neurodegenerative diseases |
| 01/06/2004 | US6673915 Nucleic acid encoding monocyte chemotactic protein 4 |
| 01/06/2004 | US6673914 Human tumor-associated gene |
| 01/06/2004 | US6673913 GANP proteins |
| 01/06/2004 | US6673912 2′-O-aminoethyloxyethyl-modified oligonucleotides |
| 01/06/2004 | US6673909 Oligonucleotides for dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophy |
| 01/06/2004 | US6673903 Antiproliferative agents |
| 01/06/2004 | US6673901 Fibronectins for use as diagnostic and treatment tools in gene therapy |
| 01/06/2004 | US6673899 Protein for use treatment of diabetes |
| 01/06/2004 | US6673898 Estrone sulfate, dehydroepiandrosterone sulfate and/or ochratoxin a; genetically engineered mutant |
| 01/06/2004 | US6673897 Inhibitors of NF-κB Activation |
| 01/06/2004 | US6673895 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 01/06/2004 | US6673778 Administering transdermally morpholino antisense oligomer to reduce expression of cytochrome p450 enzyme that catalyzes metabolism of drug, by hybridizing to target rna molecule which encodes enzyme, thus inhibiting metabolism of drug |
| 01/06/2004 | US6673776 Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673631 Simultaneous isolation and quantitation of DNA |
| 01/06/2004 | US6673616 Cleavage of nucleic acid with hairpin motif using exo- or endonucleases; detection of bacterial or viral pathogens |
| 01/06/2004 | US6673613 Use of CYP52A2A promoter to increase gene expression in yeast |
| 01/06/2004 | US6673611 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
| 01/06/2004 | US6673610 Mutating nucleotide sequences; obtain nucleotide sequence, incubate with mutant primers and polymerase, amplify nucleotide sequence, digest recover product, screen for primer sequences |
| 01/06/2004 | US6673609 Diagnosing anemia |
| 01/06/2004 | US6673604 Muscle cells and their use in cardiac repair |
| 01/06/2004 | US6673602 Herpes simplex virus amplicon vector targeting system and method of using same |
| 01/06/2004 | US6673601 Plasmid; expression vector encodes glycoprotein |
| 01/06/2004 | US6673600 Transgenic C. elegans as a model organism for investigations on Alzheimer's disease |
| 01/06/2004 | US6673591 Increasing permissiveness of cell to viral replication by decreasing expression of interferon by making cell deficient in factor that regulates interferon expression in vivo |
| 01/06/2004 | US6673590 Multiply-substituted protease variants with altered net charge for use in detergents |
| 01/06/2004 | US6673588 Genetic engineered deoxyribonucleic acid codes for restriction endonucleases and modification methylases |
| 01/06/2004 | US6673585 Denaturation prevention |
| 01/06/2004 | US6673583 Recombinantly producing levodione reductase |
| 01/06/2004 | US6673582 Microbes and methods for remediation |
| 01/06/2004 | US6673581 Transformation by introducing recombinant vector into cell and producing mannose isomerase, mannose, fructose, xylulose, and lyxose; genetic engineering |
| 01/06/2004 | US6673578 High speed polymerase chain reactions |
| 01/06/2004 | US6673577 Use to confirm that nucleic acid fragments, possessing putatively identified sequences which have been predicted by use of genecalling(tm), a quantitative expression analysis technique, are actually present in the sample |
| 01/06/2004 | US6673576 Use of genetic engineering to transform corynebacterium ammoniagenes to produce 5'-inosinic acid or 5'guanylic acid for use in seasonings by introducing gene from exiguobacter-ium acetylicum for inosine-guanosine kinase activity |
| 01/06/2004 | US6673575 Use of cultured, recombinant eukaryotic cells in the production of glycoproteins for pharmaceutical use especially given the control in degree of glycosylation afforded by the procedure |
| 01/06/2004 | US6673573 Expression of immunoglobulin-cytokine fusion proteins in malignant B cells |
| 01/06/2004 | US6673571 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 01/06/2004 | US6673569 Dsb protein family, includes dsba (formation of) and dsbc (isomerizing of) disulfide bonds, and dsbb or dsbd to control the reactivity of dsba/dsbc; use to study coexpression effects of these proteins in secretion of a foreign protein |
| 01/06/2004 | US6673567 Analyzing gene expression in microorganisms comprising transforming genetic labels, inserting genes or target dna to form transposons, then cloning, screening and isolating; genetic engineering |
| 01/06/2004 | US6673564 Detecting modulators of polypeptide activity in cell; obtain cell, incubate with modulator, monitor cellular activity and compare to control |
| 01/06/2004 | US6673553 Complexing; quantitative analysis |
| 01/06/2004 | US6673541 DNA amplification of a single cell |
| 01/06/2004 | US6673537 Promoters from chlorella virus genes providing for expression of genes in prokaryotic and eukaryotic hosts |
| 01/06/2004 | US6673534 Methods for detection of mutations in myostatin variants |
| 01/06/2004 | US6673401 Laminar structure overcoating substartes |
| 01/06/2004 | US6673353 Tuberculosis vaccine |
| 01/06/2004 | US6673351 Immunotherapeutic agent comprising purified protein extract derived from killed cells of amastigotes and leishmania |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/06/2004 | US6673340 Basement membrane degrading proteases as insect toxins and methods of use for same |
| 01/06/2004 | US6673332 Test compounds screened for ability to inhibit or enhance binding of amyloid precursor protein with kinesin-i |
| 01/06/2004 | US6673024 Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage |
| 01/06/2004 | US6672458 Efficient separation |
| 01/06/2004 | CA2142712C Bordetella bronchiseptica vaccine |
| 01/06/2004 | CA2135083C Antibodies to p-selectin and their uses |
| 01/06/2004 | CA2134094C Production of recombinant human lactoferrin |
| 01/06/2004 | CA2128208C Novel seven transmembrane receptors |
| 01/06/2004 | CA2080573C Novel bioprocesses for preparing 7-aca and 7-adac |
| 01/05/2004 | CA2432942A1 Carbohydrate deficient transferrin (cdt)-specific antibodies, their preparation and use |
| 01/02/2004 | EP1376136A2 Assay for the determination of the hormonal effect of compounds |
| 01/02/2004 | EP1376128A1 Method and apparatus for impedimetric detection of one or more analytes in a sample |
| 01/02/2004 | EP1375677A1 Probes for detecting and identifying helicobacter pylori |
| 01/02/2004 | EP1375676A2 Methods of synthesizing polynucleotides by ligation of multiple oligomers |
| 01/02/2004 | EP1375674A1 Method of detecting nucleic acids using probes with fluorescent labels by analysis of the fluorescence melting curves |
| 01/02/2004 | EP1375673A1 Gene analysis method and analyzer therefor |
| 01/02/2004 | EP1375670A1 Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 01/02/2004 | EP1375669A1 Method for enhancing the disease resistance in plants by altering trehalose-6-phosphate levels |
| 01/02/2004 | EP1375668A1 Vegetative growth-specific promoter and genetically modified plants obtained thereby |
| 01/02/2004 | EP1375667A1 Rice-origin high expression polypeptide chain elongation factor promoter and method of using the same |
| 01/02/2004 | EP1375666A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof |
| 01/02/2004 | EP1375665A1 Lysomomal enzyme composition |
| 01/02/2004 | EP1375664A1 Method for the sectetion and production of protein |
| 01/02/2004 | EP1375663A1 Novel protein, dna thereof and use of the same |
| 01/02/2004 | EP1375662A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 01/02/2004 | EP1375661A1 The role of the N-myc - nm23H1/nm23H2 - cdc42 pathway in proliferation, differentiation and treatment of cancer |
| 01/02/2004 | EP1375660A1 Method of isolating nucleic acid |
| 01/02/2004 | EP1375659A1 Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions |
| 01/02/2004 | EP1375658A1 Novel clock gene promoter |
| 01/02/2004 | EP1375656A1 Novel protein and dna encoding the same |
| 01/02/2004 | EP1375655A1 Method for producing l-leucine |
| 01/02/2004 | EP1375654A2 Transgenic and cloned mammals |
| 01/02/2004 | EP1375649A1 D-amino acid oxidase from Arthrobacter protophormiae |